| Dr Michael Hunter Ryan, MD | |
|
1620 Southridge Dr Ste B, Jefferson City, MO 65109-4005 | |
| (573) 632-2780 | |
| (573) 632-2782 |
| Full Name | Dr Michael Hunter Ryan |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 37 Years |
| Location | 1620 Southridge Dr Ste B, Jefferson City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497750855 | NPI | - | NPPES |
| 203959903 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 118143 (Missouri) | Secondary |
| 208600000X | Surgery | 118143 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boone Hospital Center | Columbia, MO | Hospital |
| Entity Name | Missouri Vein Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174529739 PECOS PAC ID: 2365332574 Enrollment ID: O20040319000135 |
News Archive
Published in a recent medRxiv* paper, researchers from South Africa, the United Kingdom, and Brazil found that these mutations in SARS-CoV-2 lineages are localized to South Africa. These unique strains, not found elsewhere in the world, are thought to have contributed around 42% to the country's total infection rate.
Toronto's Centre for Addiction and Mental Health (CAMH) has been selected as one of seven adult field trial sites in North America and the only site in Canada to test proposed diagnostic criteria for the American Psychiatric Association's (APA) fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM).
The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care. To meet this need, scientists from the Suzhou Institute of Biomedical Engineering and Technology have developed a novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on hybrid capture fluorescence immunoassay (HC-FIA).
With the entry of "Millenials" into medical residency programs across the country, institutions have started to examine ways to improve programs to correspond with that generation's learning behaviors and preferences.
Guided Therapeutics, Inc., today announced that it has submitted its premarket approval (PMA) Amendment for the LuViva Advanced Cervical Scan, a non-invasive device used to detect cervical disease that leads to cancer, instantly and at the point of care.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Hunter Ryan, MD 1620 Southridge Dr Ste B, Jefferson City, MO 65109-4005 Ph: (573) 632-2780 | Dr Michael Hunter Ryan, MD 1620 Southridge Dr Ste B, Jefferson City, MO 65109-4005 Ph: (573) 632-2780 |
News Archive
Published in a recent medRxiv* paper, researchers from South Africa, the United Kingdom, and Brazil found that these mutations in SARS-CoV-2 lineages are localized to South Africa. These unique strains, not found elsewhere in the world, are thought to have contributed around 42% to the country's total infection rate.
Toronto's Centre for Addiction and Mental Health (CAMH) has been selected as one of seven adult field trial sites in North America and the only site in Canada to test proposed diagnostic criteria for the American Psychiatric Association's (APA) fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM).
The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care. To meet this need, scientists from the Suzhou Institute of Biomedical Engineering and Technology have developed a novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on hybrid capture fluorescence immunoassay (HC-FIA).
With the entry of "Millenials" into medical residency programs across the country, institutions have started to examine ways to improve programs to correspond with that generation's learning behaviors and preferences.
Guided Therapeutics, Inc., today announced that it has submitted its premarket approval (PMA) Amendment for the LuViva Advanced Cervical Scan, a non-invasive device used to detect cervical disease that leads to cancer, instantly and at the point of care.
› Verified 7 days ago
Carl Raymond Doerhoff, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1705 Christy Dr, Suite 215, Jefferson City, MO 65101 Phone: 573-659-5500 Fax: 573-659-5505 | |
Ani Gunyaporn Nathalang-pinon, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1125 Madison St, Jefferson City, MO 65101 Phone: 573-632-5700 Fax: 573-632-5715 | |
Dr. Caleb Steffen, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-5264 Fax: 573-634-7423 | |
Dr. Jonathan M. Roberts, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-556-7722 Fax: 573-635-1527 | |
Dr. Benjamin Smith Gaddy Ii, DO Surgery Medicare: Not Enrolled in Medicare Practice Location: 3702 W Truman Blvd, Suite 104, Jefferson City, MO 65109 Phone: 573-635-5315 Fax: 573-635-5512 | |
Dr. Alan Roy Doerhoff, M D Surgery Medicare: Not Enrolled in Medicare Practice Location: 4606 Shepherd Hills Rd, Jefferson City, MO 65101 Phone: 573-230-5444 | |
Michael L. Craighead, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1100 Highland Ridge Dr, Jefferson City, MO 65109 Phone: 573-690-5881 |